The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal, multi-center, observational study. The overall goal of ADNI is to validate biomarkers for Alzheimer’s disease (AD) clinical trials.

All ADNI data are shared through the LONI Image and Data Archive (IDA), a secure research data repository. Interested scientists may obtain access to ADNI imaging, clinical, genomic, and …

ADNI study data are hosted on the Image and Data Archive (IDA) by the Laboratory of Neuro Imaging (LONI) at the University of Southern California. Qualified researchers worldwide can submit an online …

Data, including clinical, biofluid, genetic, imaging, and neuropathology results from ADNI participants, are shared with approved researchers through the LONI Image and Data Archive (IDA), a secure …

ADNI4 builds on the extensive history of the study but aims to make ADNI data more broadly relevant and generalizable to the North American population. ADNI4 continues to aid in the discovery, …

The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of …

The MRI component of the ADNI data set is rich and complex, and protocols have evolved over time. This page provides a brief high-level overview of how MRI scans have been acquired, processed, …

The ADNI publication AI is a multi-lingual system capable of answering questions in multiple languages. Its responses are primarily based on information from ADNI publications.

Please review the Schedule of Events in the ADNI Protocols (specific to each phase of the ADNI study) located on the ADNI Documentation page. Study dates are available for reconciliation between MR …

ADNI has been active for 20 years, and the types of PET data collected has evolved over time. This graphic shows which scans were collected at different times across the different phases of ADNI, …